Correction to: Real-World Recurrence Rates and Economic Burden in Patients with Resected Early-Stage Melanoma
The presentation of the numbers of patients in Tables 1 and 3 was adjusted
Main Authors: | Sekwon Jang, Tayla Poretta, Tarun Bhagnani, Qing Harshaw, Matthew Burke, Sumati Rao |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-07-01
|
Series: | Dermatology and Therapy |
Online Access: | https://doi.org/10.1007/s13555-020-00422-7 |
Similar Items
-
Real-World Recurrence Rates and Economic Burden in Patients with Resected Early-Stage Melanoma
by: Sekwon Jang, et al.
Published: (2020-06-01) -
220 Real-world outcomes of patients with resected stage IIIA melanoma treated with adjuvant nivolumab
by: Wolfram Samlowski, et al.
Published: (2020-11-01) -
Cost-effectiveness analysis of PET/CT surveillance imaging to detect systemic recurrence in resected stage III melanoma: study protocol
by: Alexander M Menzies, et al.
Published: (2020-11-01) -
The Proportion Cured of Patients with Resected Stage II–III Cutaneous Melanoma in Sweden
by: Hanna Eriksson, et al.
Published: (2021-05-01) -
Very late local recurrence of uveal melanoma following successful trans-scleral local resection
by: Aaron Jamison, et al.
Published: (2020-12-01)